Navigation Links
Lilly Reports Fourth-Quarter and Full-Year 2010 Results, Provides 2011 Financial Guidance
Date:1/27/2011

new companion animal products. Assurity™ is a topical flea treatment solely for cats, while Trifexis™ is a broad-spectrum canine parasiticide.  
  • The company suspended all current studies evaluating tasisulam as a second-line treatment for those with unresectable or metastatic melanoma. Tasisulam, an investigational, small-molecule anti-cancer compound, continues to be studied in other types of cancers.
  • The company notified its partner, MacroGenics Inc., of its decision to terminate the collaboration agreement for the development of teplizumab.

    • Fourth-Quarter Reported Results

    In the fourth quarter of 2010, worldwide total revenue was $6.187 billion, an increase of 4 percent compared with the fourth quarter of 2009. This 4 percent revenue growth was comprised of an increase of 3 percent in volume and 2 percent due to higher prices, offset by a 1 percent decrease due to the impact of foreign exchange rates. Total revenue in the U.S. increased 5 percent to $3.420 billion primarily due to higher prices and, to a lesser extent, increased volume. Total revenue outside the U.S. increased 4 percent to $2.767 billion due to increased demand, partially offset by the negative impact of foreign exchange rates and lower prices. Fourth-quarter 2010 total revenue was reduced by approximately $70 million due to the impact of U.S. health care reform.

    Gross margin increased 10 percent in the fourth quarter of 2010. Gross margin as a percent of total revenue was 80.1 percent, reflecting an increase of 4.2 percentage points compared with the fourth quarter of 2009. This increase was due to the impact of changes in foreign currencies compared to the U.S. dollar on international inventories sold, which slightly decreased cost of sales in the fourth quarter of 2010, but significantly increased cost of sales in the fourth quarter of 2009. To a lesser extent, the increase in gross margin as a percent of revenue was also due to low
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
    2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
    3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
    4. Lilly Receives NCQA Design Certification for Depression Care Management Program
    5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
    6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
    7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
    8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
    9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
    10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
    11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... -- Sanofi (EURONEXT: SAN and NYSE: SNY ) announced ... , examining the selective JAK2 inhibitor SAR302503 for myelofibrosis ... The primary endpoint assessed the proportion of patients achieving ... in previous trials, the most common adverse events were ... presented at an upcoming medical congress. ...
    (Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
    (Date:5/16/2013)... 16, 2013  PTC Therapeutics, Inc., today announced that ... with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The number of shares to be offered and ... determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... joint book-running managers for the offering. Cowen and Company ...
    Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
    ... Conn. , May 14 Zargis Medical Corp., ... today announced that its Zargis Cardioscan device and the compatible ... of a Gold Award on April 29th at ... Channel in New York City . The prestigious Gold ...
    ... , Germany , May 14, 2010 On ... international user meeting of endoscopic,spinal surgery in Veenhuizen/Niederlande. Besides the ten ... Europe , the United States ,and other countries are expected ... will be opened with a keynote lecture of,Prof. Dr. Gerbrand ...
    Cached Medicine Technology:Zargis Medical Strikes Gold at 2010 Edison Awards 2joimax(R) Holds the First International TESSYS(R) User Meeting in Veenhuizen, The Netherlands, and Announces the Launch of Various New Products for Endoscopic Spinal Surgery 2
    (Date:5/18/2013)... Angeles, California (PRWEB) May 18, 2013 Online ... to be Rolex watch owners at a fraction ... collection of luxury timepieces in the world, buyers are urged ... As compared to buying a Rolex watch from a brick-and-mortar ... pre owned Rolex watches priced at unbelievable rates. Although ...
    (Date:5/18/2013)... Dennis Thompson HealthDay Reporter , , FRIDAY, May ... unveils the latest edition of what is considered the ... its many changes continues. "This is unprecedented, the ... Jeffrey Lieberman, president-elect of the American Psychiatric Association (APA). ... what it is. You have to evaluate it and ...
    (Date:5/18/2013)... a few extra cups of coffee each month might ... known as primary sclerosing cholangitis (PSC), a new study ... Minn., found that drinking coffee was associated with a ... to cirrhosis of the liver, liver failure and biliary ... relationship. "While rare, PSC has extremely detrimental ...
    (Date:5/18/2013)... 2013) The use of a smartphone application ... to new research presented today at Digestive Disease ... in advance of the procedure, includes dietary restrictions ... taken at strict intervals. The better the preparation, ... cancer and precancerous polyps in the colon. The ...
    (Date:5/18/2013)... -- Regular consumption of coffee is associated with ... an autoimmune liver disease, Mayo Clinic research shows. ... Disease Week 2013 conference in Orlando, Fla. ... bile ducts that results in inflammation and subsequent ... liver, liver failure and biliary cancer. , "While ...
    Breaking Medicine News(10 mins):Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 2Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 3Health News:Latest Edition of Psychiatry's 'Bible' Launched Amid Controversy 4Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New smartphone application improves colonoscopy preparation 2
    ... confirms that hormone replacement therapy (HRT) should not be prescribed ... help prevent chronic conditions such as heart disease . ... safe short term treatment for younger women in early menopause ... ,In 2002, the Womens Health Initiative (WHI) trial found that ...
    ... have, the slower you age . ,Researchers at ... moles in a study of 1,800 twins, at the Twin Research Unit ... the more likely their DNA was to have the properties to fight ... in spite of the fact that moles are linked with ...
    ... 13 million kilograms of antibiotics are used to raise ... are used for growth advancement and disease prevention ... up as manure, which is commonly applied to agricultural ... on manure-altered soils are exposed to antibiotics. , ...
    ... Thiruvananthapuram Zoo has barred the entry of visitors for a week ... reportedly lost its entire stock of Indian gaur (Bos Gaurus) -- ... the week gone by. ,It was confirmed last ... the death of animals. ,The zoo was being ...
    ... to a particular variety of sugar present on the surface ... are regarded as mindless killers. White blood cells (WBC) form ... our internal body. They protect our body from various kinds ... wiping out any intruder that invades the body. A new ...
    ... she feared that her recent miscarriage was god's way of punishing ... lost her baby when she was three months pregnant, said that ... of this year, she thought she would never recover after losing ... is all this happening?' I thought it was God's punishment for ...
    Cached Medicine News:Health News:Study Confirms No HRT Benefit for Older Women 2Health News:Study Confirms No HRT Benefit for Older Women 3Health News:Dotted All Over? - Count Yourself Lucky 2Health News:Contamination of the Environment by Antibiotics Fed to Livestock 2Health News:WBC Selective About Sugar 2
    ... fully threaded 2.4 mm diameter titanium suture anchor. ... using either a powered handpiece or manually with ... implant is ideal for Bankart and SLAP repairs ... very high pull-out strengths. FASTak anchors are available ...
    ... The Bio-Corkscrew FT (fully threaded) is a ... to be inserted flush with the cortical ... anchor stability. The fully threaded design substantially ... with protruding eyelets. The fully threaded design ...
    ... is a 3 mm x 14 mm bioabsorbable ... the shoulder, knee, elbow and ankle. The exclusive ... body of the anchor and provides superior resistance ... This unique eyelet design allows the attached suture ...
    ... Suture Kit is available for ... procedures. This kit contains a ... three different colored versions of ... differentiation, large cutting Spring Eye ...
    Medicine Products: